Literature DB >> 32945831

The Opioid Epidemic During the COVID-19 Pandemic.

Danielle F Haley1, Richard Saitz1,2,3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32945831     DOI： 10.1001/jama.2020.18543

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  36 in total

1.  Ripple Collision of Three Epidemics: Vaping, Opioid Use, and COVID-19.

Authors:  Zouina Sarfraz; Azza Sarfraz; Muzna Sarfraz; Krunal Pandav; George Michel
Journal:  Addict Health       Date:  2021-10

2.  Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN).

Authors:  Kara Zivin; Lindsay Allen; Andrew J Barnes; Stefanie Junker; Joo Yeon Kim; Lu Tang; Susan Kennedy; Katherine A Ahrens; Marguerite Burns; Sarah Clark; Evan Cole; Dushka Crane; David Idala; Paul Lanier; Shamis Mohamoud; Marian Jarlenski; Mary Joan McDuffie; Jeffery Talbert; Adam J Gordon; Julie M Donohue
Journal:  Med Care       Date:  2022-07-15       Impact factor: 3.178

3.  Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.

Authors:  Hsien-Chang Lin; Zhi Wang; Yi-Han Hu; Kosali Simon; Anne Buu
Journal:  Prev Med       Date:  2022-06-21       Impact factor: 4.637

Review 4.  Opioid Use Consequences, Governmental Strategies, and Alternative Pain Control Techniques Following Total Hip Arthroplasties.

Authors:  Kevin Berardino; Austin H Carroll; Daniel Popovsky; Robert Ricotti; Matthew D Civilette; William F Sherman; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 5.  Understanding and countering opioid-induced respiratory depression.

Authors:  Jordan T Bateman; Sandy E Saunders; Erica S Levitt
Journal:  Br J Pharmacol       Date:  2021-06-05       Impact factor: 8.739

6.  Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge.

Authors:  Addison E Stone; Sarah E Scheuermann; Colin N Haile; Gregory D Cuny; Marcela Lopez Velasquez; Joshua P Linhuber; Anantha L Duddupudi; Jennifer R Vigliaturo; Marco Pravetoni; Therese A Kosten; Thomas R Kosten; Elizabeth B Norton
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

7.  Integrated substance use and prenatal care delivery in the era of COVID-19.

Authors:  Elizabeth W Patton; Kelley Saia; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-02

8.  Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder.

Authors:  Kirsten J Langdon; Caroline Scherzer; Susan Ramsey; Kate Carey; Josiah Rich; Megan L Ranney
Journal:  J Subst Abuse Treat       Date:  2021-06-16

Review 9.  Benefit-Risk Analysis of Buprenorphine for Pain Management.

Authors:  Martin Hale; Mark Garofoli; Robert B Raffa
Journal:  J Pain Res       Date:  2021-05-24       Impact factor: 3.133

10.  Barriers and Motivators to Opioid Treatment Among Suburban Women Who Are Pregnant and Mothers in Caregiver Roles.

Authors:  Miriam Boeri; Aukje K Lamonica; Jeffrey M Turner; Amanda Parker; Grace Murphy; Carly Boccone
Journal:  Front Psychol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.